Exelixis | SCHULD



Debt Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 32.84B 1.19B 2025-06
Bayer EUR 39.39B 1.31B 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Cytokinetics USD 658.13M 1.01M 2025-03
Eisai JPY 187.52B 31.58B 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Exelixis USD 179.84M 179.84M 2025-06
Genmab DKK 143M 886M 2025-03
Glaxosmithkline GBP 16.99B 927M 2024-12
Incyte USD 42.41M 5.29M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
MacroGenics USD 0 0 2024-12
Merck USD 34.84B 2.27B 2025-03
Moderna USD 745M 683M 2025-03
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Novartis USD 31.27B 12M 2025-03
Pfizer USD 62.11B 2.24B 2025-03
Sanofi 17.91B 5.85B 2024-12
Takeda JPY 4.51T 9.32B 2025-06
Ultragenyx Pharmaceutical USD 0 0 2024-12
Xencor USD 154.38M 9.23M 2025-03


Exelixis SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.